Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-2025Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Brügger, Urs | - |
| dc.contributor.author | Ruckstuhl, Andreas | - |
| dc.contributor.author | Horisberger, Bruno | - |
| dc.contributor.author | Gratwohl, Alois | - |
| dc.date.accessioned | 2018-06-25T14:18:49Z | - |
| dc.date.available | 2018-06-25T14:18:49Z | - |
| dc.date.issued | 2014-08-07 | - |
| dc.identifier.issn | 0266-4623 | de_CH |
| dc.identifier.issn | 1471-6348 | de_CH |
| dc.identifier.uri | https://digitalcollection.zhaw.ch/handle/11475/7264 | - |
| dc.description.abstract | Objectives: The aim of this study was to assess incidence, time frame, and outcome of “Coverage with Evidence Development” (CED) decisions in the Swiss Basic Health Insurance scheme. Methods: Analysis of all controversial medical technologies submitted to review by the Swiss Federal Office of Public Health (FOPH) from 1996 to 2012 with focus on decisions with constraints. Description of types of technology, type of initial decision, duration of evaluation period, final decision, and search for potential factors associated with changes over time. Results: Forty-five (37.5 percent) of 120 controversial health technologies were classified as “yes, in evaluation, reimbursed” for a certain period of time and thirty-five (29.2 percent) as “no, in evaluation, not reimbursed” by the Federal Department of Home Affairs from 1996 to 2012. The rate of CED decisions ranged between zero and nine per year and was influenced by type of technology and calendar year. Forty-four of forty-five decisions were subject to further restrictions, to a “center or a specialist” (76 percent), “indications” (49 percent), “registry” (31 percent), or “other” (49 percent). The time to a final decision ranged from 1.5 to 11 years (median, 6 years). No factors associated with initial decision and final outcome could be identified. Conclusions: CED as a reality in Switzerland might have enabled patients to obtain access to promising technologies early in their life cycle. CED might have acted as a trigger to a successful implementation of a comprehensive national registry. The lack of qualitative data stresses the urgent need for evaluation of the HTA decisions and their impact on patient outcome and costs. | de_CH |
| dc.language.iso | en | de_CH |
| dc.publisher | Cambridge University Press | de_CH |
| dc.relation.ispartof | International Journal of Technology Assessment in Health Care | de_CH |
| dc.rights | http://creativecommons.org/licenses/by-nc-sa/3.0/ | de_CH |
| dc.subject | Health technology assessment | de_CH |
| dc.subject | Coverage with evidence development | de_CH |
| dc.subject.ddc | 610: Medizin und Gesundheit | de_CH |
| dc.title | Development of coverage with evidence development for medical technologies in Switzerland from 1996 to 2012 | de_CH |
| dc.type | Beitrag in wissenschaftlicher Zeitschrift | de_CH |
| dcterms.type | Text | de_CH |
| zhaw.departement | School of Engineering | de_CH |
| zhaw.organisationalunit | Institut für Datenanalyse und Prozessdesign (IDP) | de_CH |
| dc.identifier.doi | 10.21256/zhaw-2025 | - |
| dc.identifier.doi | 10.1017/S0266462314000233 | de_CH |
| zhaw.funding.eu | No | de_CH |
| zhaw.issue | 3 | de_CH |
| zhaw.originated.zhaw | Yes | de_CH |
| zhaw.pages.end | 259 | de_CH |
| zhaw.pages.start | 253 | de_CH |
| zhaw.publication.status | publishedVersion | de_CH |
| zhaw.volume | 30 | de_CH |
| zhaw.publication.review | Peer review (Publikation) | de_CH |
| Appears in collections: | Publikationen School of Engineering | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2014_Ruckstuhl_development_of_coverage_with_evidence.pdf | 252.1 kB | Adobe PDF |  View/Open |
Show simple item record
Brügger, U., Ruckstuhl, A., Horisberger, B., & Gratwohl, A. (2014). Development of coverage with evidence development for medical technologies in Switzerland from 1996 to 2012. International Journal of Technology Assessment in Health Care, 30(3), 253–259. https://doi.org/10.21256/zhaw-2025
Brügger, U. et al. (2014) ‘Development of coverage with evidence development for medical technologies in Switzerland from 1996 to 2012’, International Journal of Technology Assessment in Health Care, 30(3), pp. 253–259. Available at: https://doi.org/10.21256/zhaw-2025.
U. Brügger, A. Ruckstuhl, B. Horisberger, and A. Gratwohl, “Development of coverage with evidence development for medical technologies in Switzerland from 1996 to 2012,” International Journal of Technology Assessment in Health Care, vol. 30, no. 3, pp. 253–259, Aug. 2014, doi: 10.21256/zhaw-2025.
BRÜGGER, Urs, Andreas RUCKSTUHL, Bruno HORISBERGER und Alois GRATWOHL, 2014. Development of coverage with evidence development for medical technologies in Switzerland from 1996 to 2012. International Journal of Technology Assessment in Health Care. 7 August 2014. Bd. 30, Nr. 3, S. 253–259. DOI 10.21256/zhaw-2025
Brügger, Urs, Andreas Ruckstuhl, Bruno Horisberger, and Alois Gratwohl. 2014. “Development of Coverage with Evidence Development for Medical Technologies in Switzerland from 1996 to 2012.” International Journal of Technology Assessment in Health Care 30 (3): 253–59. https://doi.org/10.21256/zhaw-2025.
Brügger, Urs, et al. “Development of Coverage with Evidence Development for Medical Technologies in Switzerland from 1996 to 2012.” International Journal of Technology Assessment in Health Care, vol. 30, no. 3, Aug. 2014, pp. 253–59, https://doi.org/10.21256/zhaw-2025.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.